CAS No. |
812644-79-4 |
|---|---|
中文名称 |
(2S,5S,8S,11S,17S,20S)-2-((1H-咪唑-5-基)甲基)-20-氨基-5-((S)-仲丁基)-1-((S)-2-(((S)-1-羧基-2-苯乙基)氨甲酰基)吡咯烷-1-基)-17-(3-((二氨基亚甲基)氨基)丙基)-8-(4-羟基苄基)-11-异丙基-1,4,7,10,13,16,19-七氧代-3,6,9,12,15,18-六氮杂二十二烷-22-酸 |
英文名称 |
(2S,5S,8S,11S,17S,20S)-2-((1H-imidazol-5-yl)methyl)-20-amino-5-((S)-sec-butyl)-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-17-(3-((diaminomethylene)amino)propyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16,19-heptaoxo-3,6,9,12,15,18-hexaazadocosan-22-oic acid |
别名 |
L-Phenylalanine, L-α-aspartyl-L-arginylglycyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-;TRV056 |
标准英文名 |
(2S,5S,8S,11S,17S,20S)-2-((1H-imidazol-5-yl)methyl)-20-amino-5-((S)-sec-butyl)-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-17-(3-((diaminomethylene)amino)propyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16,19-heptaoxo-3,6,9,12,15,18-hexaazadocosan-22-oic acid |
分子式 |
C52H74N14O13 |
分子量 |
1103.25 |
精确分子量 |
1102.56 |
SMILES |
CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O |
标准SMILES |
CC(C)[C@H](NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O |
用途 |
TRV056 can be used to develop Gq-biased AT1R agonists; it is a "gain-of-function" ligand with >10-fold greater allosteric coupling to Gq than AngII and is more efficacious in stimulating cellular Gq-mediated signaling (e.g., IP1 generation). |
InChIKey |
NOMIXRQBVMELPF-IWIOKYJLSA-N |
|
|
评论 |
|---|